Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 27 Mar 23 424B5 Prospectus supplement for primary offering
- 22 Mar 23 424B5 Prospectus supplement for primary offering
- 27 Feb 23 EFFECT Notice of effectiveness
- 22 Feb 23 EFFECT Notice of effectiveness
- 15 Feb 23 424B5 Prospectus supplement for primary offering
-
10 Feb 23 S-3/A Shelf registration (amended)
- 30 Jan 23 S-3 Shelf registration
ETNB similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the use of our report dated March 24, 2022, with respect to the consolidated financial statements of 89bio, Inc., incorporated herein by reference, and to the reference to our firm under the heading “Experts” in the prospectus.
/s/ KPMG LLP
San Francisco, California
February 10, 2023